Study of Immunotherapy to Treat Advanced Prostate Cancer

NCT00861614 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

988

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ipilimumab
DRUG: Placebo

Sponsor

Bristol-Myers Squibb